Mupadolimab, the novel antibody, is attracting considerable attention within the medical arena due to its unique mechanism of function. This CD73-blocking agent selectively targets CD73, a membrane enzyme linked in https://junaidzdjx769201.pointblog.net/the-new-drug-an-potential-anti-cd73-therapeutic-demonstrates-promise-93010412